|
| | | | | | | |
Adjusted Earnings Per Share (Non-GAAP) | | | |
Earnings from continuing operations are adjusted by the effect of acquisition-related amortization, the Tax Cuts and Jobs Act, gains on disposition of businesses, disposition costs, rightsizing and other costs and a product recall reserve reversal to derive adjusted earnings from continuing operations and adjusted diluted earnings per common share as follows: |
| | 2017 |
| | Q4 | FY 2017 |
Adjusted earnings: | | | |
Earnings from continuing operations * | | $ | 289,645 |
| $ | 746,663 |
|
Acquisition-related amortization, pre-tax 1 | | 37,108 |
| 151,277 |
|
Acquisition-related amortization, tax impact 2 | | (11,906 | ) | (48,881 | ) |
Tax Cuts and Jobs Act 3 * | | (54,908 | ) | (54,908 | ) |
Gain on dispositions, pre-tax 4 | | (116,932 | ) | (205,334 | ) |
Gain on dispositions, tax impact 2 | | 6,071 |
| 32,753 |
|
Disposition costs, pre-tax 5 | | 1,931 |
| 5,245 |
|
Disposition costs, tax impact 2 | | (1,051 | ) | (2,015 | ) |
Rightsizing and other costs, pre-tax 6 | | 49,379 |
| 49,379 |
|
Rightsizing and other costs, tax impact 2 | | (14,746 | ) | (14,746 | ) |
Product recall reversal, pre-tax | | (7,200 | ) | (7,200 | ) |
Product recall reversal, tax impact 2 | | 2,614 |
| 2,614 |
|
Adjusted earnings from continuing operations | | $ | 180,005 |
| $ | 654,847 |
|
| | | |
Adjusted diluted earnings per common share**: | | | |
Diluted earnings per share from continuing operations * | | $ | 1.83 |
| $ | 4.73 |
|
Acquisition-related amortization, pre-tax 1 | | 0.23 |
| 0.96 |
|
Acquisition-related amortization, tax impact 2 | | (0.08 | ) | (0.31 | ) |
Tax Cuts and Jobs Act 3 * | | (0.35 | ) | (0.35 | ) |
Gain on dispositions, pre-tax 4 | | (0.74 | ) | (1.30 | ) |
Gain on dispositions, tax impact 2 | | 0.04 |
| 0.21 |
|
Disposition costs, pre-tax 5 | | 0.01 |
| 0.03 |
|
Disposition costs, tax impact 2 | | (0.01 | ) | (0.02 | ) |
Rightsizing and other costs, pre-tax 6 | | 0.31 |
| 0.31 |
|
Rightsizing and other costs, tax impact 2 | | (0.09 | ) | (0.09 | ) |
Product recall reversal, pre-tax | | (0.05 | ) | (0.05 | ) |
Product recall reversal, tax impact 2 | | 0.02 |
| 0.02 |
|
Adjusted diluted earnings per share from continuing operations | | $ | 1.14 |
| $ | 4.15 |
|
| | | |
1 Includes amortization on acquisition-related intangible assets and inventory step-up. |
2 Adjustments were tax effected using the statutory tax rates in the applicable jurisdictions or the effective tax rate, where applicable, for each period. |
3 Tax impact primarily related to the enactment of the Tax Cuts and Jobs Act. This benefit also includes decreases in statutory tax rates of foreign jurisdictions. |
4 Includes a gain from the sale of Warn Industries, Inc. in the fourth quarter of 2017. |
5 Disposition costs include costs related to the sale of Warn Industries, Inc. in the fourth quarter of 2017. |
6 Rightsizing and other costs include actions taken on employee reductions, facility consolidations and site closures and product line divestitures and exits. |
* The Company reclassified $53.2 million of income tax benefit related to the revaluing of December 31, 2017 deferred taxes, in accordance with ASC 740-10-45-15, from earnings from discontinued operations, net to (benefit) provision for income taxes related to continuing operations. |
** Per share data and totals may be impacted by rounding. |